Education program for HER2 breast cancer patients
Part of Cancer, Skin clinical trials.
This study is testing whether an educational program helps people with HER2 breast cancer learn more about their treatment and manage side effects. Participants will have virtual visits and watch online training videos.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have been diagnosed with HER2-positive or HER2-low breast cancer and are starting or already on a type of targeted therapy called an antibody drug conjugate (ADC)
- You can read, speak, and understand English
- You have access to a computer or iPad with internet to fill out surveys and watch training videos online
- You are willing to attend three study visits (can be virtual) and possibly do two interviews and a focus group
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different combinations of targeted therapy and chemotherapy before surgery for HER2-positive breast cancer. It uses a special PET scan to see how well the treatment is working and to help choose the best treatment plan for each person.
This study tests a new computer-based education module created by artificial intelligence to help breast cancer patients understand their diagnosis and treatment options. The goal is to see if this tool helps patients feel more informed and prepared for their care.
This study tests different treatment plans given before surgery for early breast cancer that is both hormone receptor-positive and HER2-positive. The goal is to see which treatment is more effective and to tailor it to each patient.
This study looks at the genetic details of HER2-positive breast cancer to help find subtypes and improve future treatments. It does not test a new drug but collects information from your tumor tissue to learn more about the disease.
This trial tests a digital education program that uses artificial intelligence to teach about radiation treatment and its side effects. It aims to help patients better understand and manage their care during radiation therapy.
This trial tests a neoadjuvant (before surgery) treatment plan for people with early-stage HER2-positive breast cancer. The goal is to see if a personalized approach can improve outcomes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.